SB17170 Phase 2 Trial in IPF Patients

Clinical trial NCT06747923 · RECRUITING

Trial details

NCT number: NCT06747923
Sponsor: SPARK Biopharma
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

IPF Idiopathic Pulmonary Fibrosis Idiopathic Pulmonary Fibrosis (IPF)

Start date: 2025-01-27
Primary completion: 2026-05-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.